AVGO vs DHR: Which Is the Better Buy?
Side-by-side comparison of Broadcom Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
Broadcom Inc. · Technology
$354.99
+15.1% upside to fair value
Med Conviction
Grade B
High Quality
VS
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AVGO |
DHR |
| Current Price |
$354.99 |
$221.12 |
| Fair Value Estimate |
$408.70 |
$286.52 |
| Upside to Fair Value |
+15.1%
|
+29.6%
|
| Market Cap |
$1,688.9B |
$155.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
33.0x
|
24.8x
|
| Price / Sales |
18.9x
|
6.2x
|
| Price / FCF |
42.9x
|
28.5x
|
| Revenue Growth YoY |
+85.5%
|
+5.5%
|
| Gross Margin |
67.7%
|
58.5%
|
| Operating Margin |
48.3%
|
20.4%
|
| Return on Equity |
43.9%
|
7.7%
|
| Dividend Yield |
0.73% |
0.65% |
| FCF Yield |
2.33%
|
3.51%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Broadcom is a diversified semiconductor and infrastructure software company led by CEO Hock Tan, with a portfolio spanning custom AI ASICs, networking, wireless, storage, and enterprise software. The business quality is high: TTM gross margin of 67.7%, TTM operating margin of 48.3%, TTM net margin of 42.9%, and ROE of 43.9% demonstrate exceptional profitability, while revenue growth of 85.5% and …
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Accumulation Zones
| Metric |
AVGO |
DHR |
| Zone Low |
$306.52 |
$214.89 |
| Zone High |
$347.39 |
$243.54 |
| In Buy Zone? |
No
|
Yes
|